Endogenous erythropoietin as part of the cytokine network in the pathogenesis of experimental autoimmune encephalomyelitis

Molecular Medicine

Volumn 14, Issue 11-12, 2008, Pages 682-688

  Mengozzi, Manuela ^a,e   Cervellini, Ilaria ^a   Bigini, Paolo ^a   Martone, Sara ^a   Biondi, Antonella ^a   Pedotti, Rosetta ^b   Gallo, Barbara ^b   Barbera, Sara ^a   Mennini, Tiziana ^a   Boraso, Mariaserena ^c   Marinovich, Marina ^c   Petit, Edwige ^d   Bernaudin, Myriam ^d   Bianchi, Roberto ^a   Viviani, Barbara ^c   Ghezzi, Pietro ^a,e  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITÉ DE CAEN   (France)

^e BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MESSENGER RNA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEOLIPID PROTEIN; TUMOR NECROSIS FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GLIA CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MOTONEURON; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT; SPINAL CORD; SPINAL CORD NERVE CELL;

ANIMALS; CELL LINE, TUMOR; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ERYTHROPOIETIN; FEMALE; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 55749085677     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2008-00086.Mengozzi     Document Type: Article

References (41)

1. Brines ML, et al. (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. U. S. A. 97:10526-31.
2. Ghezzi P, Brines M. (2004) Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ. 11: S37-S44.
3. Villa P, et al. (2003) Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp. Med. 198:971-5.
4. Sattler MB, et al. (2004) Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death Differ. 11 Suppl 2:S181-92.
5. Li W, et al. (2004) Beneficial effect of erythropoietin on experimental allergic encephalomyelitis. Ann. Neurol. 56:767-77.
6. Savino C, et al. (2006) Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. J. Neuroimmunol. 172:27-37.
7. Ehrenreich H, et al. (2007) Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 130:2577-88.
8. Jelkmann W. (2007) Erythropoietin after a century of research: younger than ever. Eur. J. Haematol. 78:183-205.
9. Sasaki R, Masuda S, Nagao M. (2001) Pleiotropic functions and tissue-specific expression of erythropoietin. News Physiol. Sci. 16:110-3.
10. Bernaudin M, et al. (1999) A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19:643-51.
11. Siren AL, et al. (2001) Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta. Neuropathol. (Berl.) 101:271-6.
12. Sakanaka M, et al. (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U. S. A. 95:4635-40.
13. Prass K, et al. (2003) Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 34:1981-6.
14. Graumann U, Reynolds R, Steck AJ, Schaeren-Wiemers N. (2003) Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol. 13:554-73.
15. Aboul-Enein F, et al. (2003) Preferential loss of myelin-associated glycoprotein reflects hypoxialike white matter damage in stroke and inflammatory brain diseases. J. Neuropathol. Exp. Neurol. 62:25-33.
16. Pedotti R, et al. (2001) An unexpected version of horror autotoxicus: anaphylactic shock to a selfpeptide. Nat. Immunol. 2:216-22.
17. Official Gazette of the Italian Republic, supplement 40. Legislative Decree 116. (February 18, 1992).
18. European Economic Community Council Directive 86/609. Official Journal L 358:1. (December 12, 1987).
19. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. (1996) Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press. 128 pp.
20. Overbergh L, Valckx D, Waer M, Mathieu C. (1999) Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305-12.
21. Bigini P, Mennini T. (2004) Immunohistochemical localization of TNFalpha and its receptors in the rodent central nervous system. Methods Mol. Med. 98:73-80.
22. Stolze I, et al. (2002) Hypoxia-inducible erythropoietin gene expression in human neuroblastoma cells. Blood 100:2623-8.
23. Liu C, Shen K, Liu Z, Noguchi CT. (1997) Regulated human erythropoietin receptor expression in mouse brain. J Biol. Chem. 272:32395-400.
24. Rankin EB, et al. (2007) Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J. Clin. Invest. 117:1068-77.
25. Marti HH, et al. (1996) Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 8:666-76.
26. Grasso G, et al. (2005) Erythropoietin and erythropoietin receptor expression after experimental spinal cord injury encourages therapy by exogenous erythropoietin. Neurosurgery 56:821-7.
27. Knabe W, Siren AL, Ehrenreich H, Kuhn HJ. (2005) Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root ganglia. Anat. Embryol. (Berl.) 210:209-19.
28. Kennedy MK, Torrance DS, Picha KS, Mohler KM. (1992) Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496-505.
29. Racke MK, et al. (1992) Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. Int. Immunol. 4:615-20.
30. Issazadeh S, Navikas V, Schaub M, Sayegh M, Khoury S. (1998) Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J. Immunol. 161:1104-12.
31. Fumagalli E, Bigini P, Barbera S, De Paola M, Mennini T. (2006) Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease. Exp. Neurol. 198:114-28.
32. Proescholdt MA, Jacobson S, Tresser N, Oldfield EH, Merrill MJ. (2002) Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J. Neuropathol. Exp. Neurol. 61:914-25.
33. Martinez-Estrada OM, et al. (2003) Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur J. Neurosci. 18:2538-44.
34. Semenza GL. (2001) HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 13:167-71.
35. Wiener CM, Booth G, Semenza GL. (1996) In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 225:485-8.
36. Palmer LA, Semenza GL, Stoler MH, Johns RA. (1998) Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am. J. Physiol. 274: L212-9.
37. Belaiba RS, et al. (2007) Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol. Biol. Cell 18:4691-7.
38. Bonello S, et al. (2007) Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler. Thromb. Vasc. Biol. 27:755-61.
39. Mi Z, et al. (2008) Synergystic induction of HIF-1alpha transcriptional activity by hypoxia and lipopolysaccharide in macrophages. Cell Cycle 7:232-41.
40. Oh YT, et al. (2008) Lipopolysaccharide induces hypoxia-inducible factor-1 alpha mRNA expression and activation via NADPH oxidase and Sp1-dependent pathway in BV2 murine microglial cells. Neurosci. Lett. 431:155-60.
41. Jelkmann W, Pagel H, Wolff M, Fandrey J. (1992) Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci. 50:301-8.